PRNewsWire
02 Jul 2026, 22:47 UTC · 4h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
2 claims · each scored for market impact
A class action lawsuit has been filed against Insulet Corporation alleging the company made materially false and misleading statements regarding its manufacturing controls and safety compliance. — Securities class actions create legal uncertainty, potential for significant financial settlements, and suggest systemic internal governance failures.
-0.60Insulet initiated two separate voluntary medical device corrections for Omnipod products due to manufacturing issues, including one that could result in insulin under-delivery. — Product recalls for life-critical medical devices like insulin pumps pose significant regulatory risks and can damage brand trust and market share.
-0.50Which stocks this story touches
The company is facing a class action lawsuit alleging misleading statements regarding defective manufacturing controls and safety risks.
Continue reading
6 related stories
Top 3 movers · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
PRNewsWire
5h ago
